Titan Pharmaceuticals
TTNP
#11000
Rank
HK$48.07 M
Marketcap
HK$36.14
Share price
-3.76%
Change (1 day)
16.91%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.41. In 2023 the company made an earnings per share (EPS) of -HK$58.09 an increase over its 2022 EPS that were of -HK$119.08.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.09-51.22%
2022-HK$119.08-15.61%
2021-HK$141.10-81.37%
2020-HK$757.25-77.52%
2019-HK$3,369-56.32%
2018-HK$7,714-59.51%
2017-HK$19,053-371.81%
2016HK$7,010-144.35%
2015-HK$15,804300%
2014-HK$3,951-121.54%
2013HK$18,344-151.38%
2012-HK$35,699-11.54%
2011-HK$40,356188.89%
2010-HK$13,969-10%
2009-HK$15,521
2007-HK$63,638-2.38%
2006-HK$65,190-39.13%
2005-HK$107,098-16.87%
2004-HK$128,828-22.43%
2003-HK$166,0804.9%
2002-HK$158,31961.9%
2001-HK$97,785-13.7%
2000-HK$113,30765.01%
1999-HK$68,668-35.87%
1998-HK$107,080-1824.71%
1997HK$6,209-102.4%
1996-HK$259,208

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36-252.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.16-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$36.22 5.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-HK$1.57-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.80-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.10-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA